BMC Cancer

official impact factor 3.15

Open Access Email this article to a friend

MCM2 - a promising marker for premalignant lesions of the lung: a cohort study

Dong-Feng Tan, Joel A Huberman, Andrew Hyland, Gregory M Loewen, John SJ Brooks, Amy F Beck, Ivan T Todorov and Gerold Bepler*

BMC Cancer 2001, 1:6 doi:10.1186/1471-2407-1-6

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.